Frontlight ResearchEarly access
Metastatic breast cancer trials in France
83 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleOptimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
- Where
- Villejuif
- Age
- 18 years and over
- People
- 400
- Run by
- UNICANCER
See details and how to joinNCT07259226 - Phase 2Taking peopleCapecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
- Where
- Amiens Cedex 1, Caen Cedex 5, Clermont-Ferrand, Dijon, Lyon, Montpellier Cedex 5, Nice Cedex 2, Paris, Paris Cedex 13, Reims, Rouen, Strasbourg, Villejuif
- Age
- 18 years and over
- People
- 30
- Run by
- UNICANCER
See details and how to joinNCT05800275 · EU 2022-502351-60-00 - Phase 1Taking peopleFirst-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- Where
- Bordeaux, Lyon, Villejuif
- Age
- 18 years and over
- People
- 930 worldwide
- Run by
- Relay Therapeutics, Inc.
See details and how to joinNCT05216432 - No phaseNot yet taking people in FrancePERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 262
- Run by
- Centre Paul Strauss
See details and how to joinNCT07130344 - Phase 3Taking peopleEvaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
- Where
- Grenoble
- Age
- 18 years to 99 years
- People
- 25
- Run by
- University Hospital, Grenoble
See details and how to joinNCT06611891 - Phase 2Taking peopleTucatinib in combination with Oral Etoposide (VP16) and Trastuzumab in Patients with metastatic HER2+ Breast cancer (TUC-TOC)
- Where
- Avignon, Caen Cedex 5, Dijon, Lille, Montpellier Cedex 5, Nantes Cedex 2, Paris, Plerin, Saint-Cloud
- Age
- 18 years and over
- People
- 66
- Run by
- Institut Curie
See details and how to join2022-500743-20-00 - No phaseTaking peopleTumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
- Where
- Angers, Annecy, Clermont-Ferrand, Contamine-sur-Arve, Lille, Lyon, Paris, Pierre-Bénite, Poitiers, Saint-Priest-en-Jarez, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 220
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT04170634 - Phase 3Not yet taking people in FranceThero2-01S22 in HER2-positive Breast Cancer
- Where
- Amiens Cedex 1, Nimes Cedex 9, Strasbourg
- Age
- 18 years and over
- People
- 320
- Run by
- Institut de cancérologie Strasbourg Europe
See details and how to joinNCT05698186 · EU 2024-516576-15-00